Immunotherapy vs. Chemotherapy: Key Differences, Benefits, and Considerations

Immunotherapy boosts the body's natural defenses to recognize and destroy cancer cells, while chemotherapy directly attacks rapidly dividing tumor cells to halt their replication.

Both modalities are cornerstone cancer treatments. They may be used alone, together, or alongside surgery, radiation, or targeted therapies, depending on the individual case.

Read on to understand how immunotherapy and chemotherapy compare across mechanism, delivery, effectiveness, side‑effects, and cost.

• Genetic alterations that hide cancer cells from immune surveillance
• Proteins that switch off immune‑cell activity
• Changes in the tumor microenvironment that impede an immune response

How Immunotherapy Works

Immunotherapy drugs train the immune system—particularly T‑cells, a type of white blood cell—to identify and eliminate cancer cells. The ultimate aim is a durable, tumor‑specific immune response that can persist after treatment ends.

Research in this field is expanding rapidly, and many experts anticipate breakthrough therapies in the coming years.

Delivery of Immunotherapy

Most immunotherapy agents are administered intravenously, though some are given subcutaneously or orally, depending on the product. While immunotherapy is approved for a growing list of malignancies, it is still less universally applied than chemotherapy, radiation, or surgery.

How Chemotherapy Works

Since the 1940s, chemotherapy has been the primary chemical approach to cancer care. These drugs interfere with DNA replication, thereby preventing cancer cells from dividing and spreading.

Therapeutic Goals of Chemotherapy

• Reduce tumor burden
• Lower the risk of metastasis or recurrence
• Shrink masses to make surgery or radiation more effective
• Alleviate cancer‑related symptoms

Delivery of Chemotherapy

Chemotherapy can be given intravenously, orally, intramuscularly, or directly into the tumor cavity. Because the agents also affect normal rapidly dividing cells, side effects such as hair loss, nausea, and fatigue are common.

Comparative Overview

Neither treatment is universally superior; the optimal choice depends on tumor biology, stage, location, and patient health.

Speed of Action

Chemotherapy often produces a rapid reduction in tumor size, sometimes within weeks. Immunotherapy may require several weeks to months before a measurable response is seen, as the immune system ramps up.

Durability of Effect

When chemotherapy stops, its anti‑cancer activity ceases. Immunotherapy can continue to stimulate immune surveillance, potentially offering lasting protection after the course ends.

Side‑Effect Profiles

Chemotherapy’s toxicity stems from damage to healthy proliferating cells, leading to hair loss, skin changes, blood‑cell suppression, and gastrointestinal upset.

Immunotherapy side effects are usually immune‑mediated and may include:

• Skin rash
• Cough or shortness of breath
• Abdominal discomfort
• Diarrhea

In rare cases, an overactive immune response can target vital organs, requiring prompt medical management.

Cost Considerations

Both therapies vary widely in price based on treatment duration, cancer type, and disease stage. A 2024 systematic review reported that immune‑checkpoint inhibitors were generally more cost‑effective than chemotherapy for advanced non‑small cell lung cancer.

Most private insurers and Medicare now cover many immunotherapy agents, but out‑of‑pocket expenses can differ. Patients should verify coverage with their insurance provider.

Making the Right Choice

Oncologists evaluate multiple factors—genetic markers, tumor location, overall health, and patient preferences—when recommending immunotherapy, chemotherapy, or a combination.

Discuss the potential benefits, risks, and financial implications with your care team to develop a personalized, evidence‑based treatment plan.